FLUPHENAZINE DECANOATE INJECTION B.P. 25 MG — DIN 02189089
FLUPHENAZINE DECANOATE : 25 MG · HOSPIRA HEALTHCARE ULC · LIQUID · wholesale supply in Canada
Health Canada status: CANCELLED PRE MARKET
What is FLUPHENAZINE DECANOATE INJECTION B.P.?
FLUPHENAZINE DECANOATE INJECTION B.P. 25 MG contains FLUPHENAZINE DECANOATE : 25 MG. It is listed in the Health Canada Drug Product Database under DIN 02189089, held by HOSPIRA HEALTHCARE ULC, supplied as LIQUID for INTRAMUSCULAR ; SUBCUTANEOUS administration. Health Canada currently lists it as cancelled pre market, status dated 15-Apr-2019. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.
How much does Fluphenazine cost around the world?
Fluphenazine is listed on 4 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Lebanon publishes a public price (USD, Decision 119/1); Morocco publishes a PPV (public price); South Africa publishes a single exit price. Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| United States | acquisition | 4 | 77 | USD███.██ |
| South Africa | single exit price | 1 | 3 | ZAR███.██ |
| Morocco | PPV (public price) | 2 | 2 | MAD███.██ |
| Lebanon | public price (USD, Decision 119/1) | 1 | 1 | USD███.██ |
83 pack listings across 8 brand entries and 4 price bases, refreshed 05 Sep 2026. Ranges span every Fluphenazine pack in that market, so a high figure is usually a larger pack rather than the same product.
This table is a regulatory record of where the molecule is listed. The DIN on this page is no longer authorized for sale in Canada, so Nexara does not quote it — see the alternatives above.
Is there a generic Fluphenazine in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
10 holders have a Canadian DIN containing Fluphenazine, across 25 DINs, of which 3 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| AA PHARMA INC | 3 | 3 | FLUPHENAZINE | Sourceable in Canada |
| PHARMASCIENCE INC | 6 | 0 | PMS FLUPHENAZINE TAB 1MG, PMS FLUPHENAZINE TAB 2MG, PMS FLUPHENAZINE TAB 5MG, PMS-FLUPHENAZINE DECANOATE, PMS-FLUPHENAZINE DECANOATE INJ (BP) 25MG/ML, +1 more | No marketed DIN |
| PRO DOC LIMITEE | 3 | 0 | FLUPHENAZINE 1 TAB 1MG, FLUPHENAZINE 2 TAB 2MG, FLUPHENAZINE 5 TAB 5MG | No marketed DIN |
| SQUIBB CANADA INC., DIVISION OF BRISTOL-MYERS SQUIBB CANADA INC. | 3 | 0 | MODECATE INJ 25MG/ML, MODITEN ENANTHATE INJ 25MG/ML, MODITEN HCL TAB 10MG | No marketed DIN |
| APOTEX INC | 2 | 0 | APO FLUPHENAZINE TAB 2.5MG, APO-FLUPHENAZINE INJECTABLE | No marketed DIN |
| HOSPIRA HEALTHCARE ULC | 2 | 0 | FLUPHENAZINE DECANOATE INJECTION B.P. | No marketed DIN |
| OMEGA LABORATORIES LIMITED | 2 | 0 | FLUPHENAZINE OMEGA | No marketed DIN |
| RHODIAPHARM INC | 2 | 0 | RHO-FLUPHENAZINE DECANOATE INJ-25MG/ML IM SC, RHO-FLUPHENAZINE DECANOATE INJ.CONC-100MG/ML | No marketed DIN |
| BRISTOL-MYERS SQUIBB CANADA | 1 | 0 | MODECATE CONCENTRATE | No marketed DIN |
| MYLAN PHARMACEUTICALS ULC | 1 | 0 | FLUPHENAZINE DECANOATE INJECTION, USP | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 25 MG |
|---|---|
| Dosage form | LIQUID |
| Route | INTRAMUSCULAR ; SUBCUTANEOUS |
Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.
Substance and classification
| Active substance | Fluphenazine |
|---|---|
| ATC code | N05AB02 |
| AHFS class | 28:16.08.24 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02189089 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2189089 |
| Brand name | FLUPHENAZINE DECANOATE INJECTION B.P. |
| Generic / active ingredient | FLUPHENAZINE DECANOATE : 25 MG |
| Market authorization holder | HOSPIRA HEALTHCARE ULC |
| Health Canada schedule | Prescription |
| ATC code | N05AB02 |
| ATC anatomical main group | N — Nervous system |
| ATC therapeutic subgroup | N05AB |
| Current status | CANCELLED PRE MARKET |
| Status date | 15-Apr-2019 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
Is Fluphenazine in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Resolved — reported by AA PHARMA INC, last seen 09 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
Check availability for FLUPHENAZINE DECANOATE INJECTION B.P.
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
3 of 25 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| FLUPHENAZINE | 1 MG | TABLET | AA PHARMA INC | MARKETED | 00405345 |
| FLUPHENAZINE | 5 MG | TABLET | AA PHARMA INC | MARKETED | 00405361 |
| FLUPHENAZINE | 2 MG | TABLET | AA PHARMA INC | MARKETED | 00410632 |
| APO FLUPHENAZINE TAB 2.5MG | 2.5 MG | TABLET | APOTEX INC | CANCELLED POST MARKET | 00405353 |
| APO-FLUPHENAZINE INJECTABLE | 25 MG | LIQUID | APOTEX INC | CANCELLED POST MARKET | 02244166 |
| FLUPHENAZINE 1 TAB 1MG | 1 MG | TABLET | PRO DOC LIMITEE | CANCELLED POST MARKET | 00563846 |
| FLUPHENAZINE 2 TAB 2MG | 2 MG | TABLET | PRO DOC LIMITEE | CANCELLED POST MARKET | 00563838 |
| FLUPHENAZINE 5 TAB 5MG | 5 MG | TABLET | PRO DOC LIMITEE | CANCELLED POST MARKET | 00563803 |
| FLUPHENAZINE DECANOATE INJECTION B.P. | 100 MG | LIQUID | HOSPIRA HEALTHCARE ULC | CANCELLED PRE MARKET | 02189097 |
| FLUPHENAZINE DECANOATE INJECTION, USP | 25 MG | SOLUTION | MYLAN PHARMACEUTICALS ULC | CANCELLED PRE MARKET | 02383225 |
2 · Same class — other molecules in ATC N05AB
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Perphenazine | PERPHENAZINE · PERPHENAZINE 16 TAB · PERPHENAZINE 2 TAB 2MG · PERPHENAZINE 8 TAB 8MG · +17 more | 25 | 4 | Yes |
| Fluphenazine | APO FLUPHENAZINE TAB 2.5MG · APO-FLUPHENAZINE INJECTABLE · FLUPHENAZINE · FLUPHENAZINE 1 TAB 1MG · +17 more | 25 | 3 | Yes |
| Prochlorperazine | NU-PROCHLOR TAB 10MG · NU-PROCHLOR TAB 5MG · ODAN-PROCHLORPERAZINE · PMS PROCHLORPERAZINE INJ 5MG/ML · +9 more | 15 | 3 | Yes |
| Trifluoperazine | NOVO-FLURAZINE TAB 1MG · NOVO-FLURAZINE TAB 20MG · NOVO-TRIFLUZINE - TAB 10MG · NOVO-TRIFLUZINE - TAB 2MG · +26 more | 38 | 0 | Not in Canada |
| Thioproperazine | MAJEPTIL | 1 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC N05A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| N05AH | Asenapine · Clozapine · Loxapine · Olanzapine · Quetiapine | 589 | 220 |
| N05AX | Aripiprazole · Brexpiprazole · Cariprazine · Paliperidone · Risperidone | 352 | 175 |
| N05AE | Lurasidone · Ziprasidone | 60 | 41 |
| N05AD | Droperidol · Haloperidol | 53 | 9 |
| N05AF | Flupentixol · Tiotixene · Zuclopenthixol | 25 | 8 |
| N05AA | Chlorpromazine · Levomepromazine · Promazine | 51 | 8 |
| N05AN | Lithium | 26 | 7 |
| N05AC | Mesoridazine · Periciazine · Pipotiazine · Thioridazine | 32 | 3 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is FLUPHENAZINE DECANOATE INJECTION B.P. called?
Also recorded in Canada as: fluphenazine decanoate 25 MG/ML Injectable Solution (US), fluphenazine decanoate 100 MG/ML Injectable Solution (US), FLUPHENAZINE DECANOATE (US).
The same molecule, Fluphenazine, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Modecate | Latin | Morocco, South Africa |
| FLUPHENAZINE HCl | Latin | Lebanon |
| MODITEN | Latin | Morocco |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
Can this still be bought in Canada?
No. This Drug Identification Number is cancelled pre market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.
If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.